Concepedia

Silvia Maifrede

SM

Statistics

Publications

10

Citations

418

H-Index

10

Active since

2016

Affiliations

Temple University(Current)

Instytut Biologii Doświadczalnej im. Marcelego Nenckiego

University of Pennsylvania

Fox Chase Cancer Center

Medical University of Vienna

Silvia Maifrede is an author at Temple University specializing in oncology, molecular oncology, and parp inhibition.

Publications per year

2016–2021

10

Publications

10

Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms

Margaret Nieborowska-Skorska, Silvia Maifrede, Yashodhara Dasgupta et al. · Blood · 2017 · 77 citations · Full text

, , +17

Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells

Margaret Nieborowska-Skorska, Katherine Sullivan, Yashodhara Dasgupta et al. · Journal of Clinical Investigation · 2017 · 76 citations · Full text

, , +17

Tyrosine kinase inhibitor–induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors

Silvia Maifrede, Margaret Nieborowska-Skorska, Katherine Sullivan-Reed et al. · Blood · 2018 · 75 citations · Full text

, , +17

<i>TET2</i> and <i>DNMT3A</i> Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors

Silvia Maifrede, Bac Viet Le, Margaret Nieborowska-Skorska et al. · Cancer Research · 2021 · 51 citations · Full text

, , +17

MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs

Silvia Maifrede, Esteban Martı́nez, Margaret Nieborowska-Skorska et al. · Blood Advances · 2017 · 33 citations · Full text

, , +9

1–5 of 10